LSC
IMI

Lyon Street Capital’s Intermolecular, Inc. IMI Stock Holding History

Lyon Street Capital’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-694,686
Closed -$3.83M – 43
2013
Q3 		$3.83M Buy
694,686
+55,519
+9% +$349K 1.89% 23
2013
Q2 		$4.65M Buy
+639,167
New +$5.44M 2.3% 17

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lyon Street Capital's IMI Position: Q4 2013 in Review

Lyon Street Capital sold out of Intermolecular, Inc. (IMI) in Q4 2013, closing a stake of 694,686 shares — an estimated $3.83M sold.

Lyon Street Capital first reported a position in IMI in Q2 2013 and held it in 2 quarters. The position peaked at $4.65M in Q2 2013. 53 funds tracked by Wall St. Rank hold IMI as of Q4 2013.

  • Lyon Street Capital reported no remaining Intermolecular, Inc. position as of Q4 2013 after selling out during the quarter.
  • Lyon Street Capital sold 694,686 Intermolecular, Inc. shares in Q4 2013, an estimated $3.83M.
  • Lyon Street Capital first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 2 quarters.
  • Lyon Street Capital's Intermolecular, Inc. position peaked at $4.65M in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2013.

Based on Lyon Street Capital's 13F filing for Q4 2013, filed 30 Jan 2014.